Dr. Rachel Ann Mann, MD

Dr. Mann practices at HealthPartners Specialty Center-Orthopaedic and Sports Medicine in Saint Paul, Minnesota.

Dr. Mann's NPI, 1548757909, was assigned on April 20, 2018. Dr. Mann graduated from University Of Michigan Medical School in 2018. Dr. Mann holds Massachusetts license 1016619.

Dr. Mann's primary practice is HealthPartners Specialty Center-Orthopaedic and Sports Medicine, at 435 Phalen Blvd, Saint Paul, MN 55130 in Ramsey County. The practice phone is (651) 254-0900.

Dr. Mann's primary practice is HealthPartners Specialty Center-Orthopaedic and Sports Medicine in Saint Paul, Minnesota. Dr. Mann is also affiliated with Gillette Children's. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Mann to 5 more hospitals, 5 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mann practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Mann's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Mann's licenses on file in 2 states: Massachusetts and Minnesota.

CMS data shows 11 Medicare services from Dr. Mann across 1 procedure code in 2024, all of them office visits, for 73 Medicare patients. Medicare paid $439 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 73 Medicare patients who saw Dr. Mann in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mann's median patient age at 47, with 25% women.

In 2024, Dr. Mann wrote 160 Medicare Part D claims for 71 patients. 83% of them were for generic drugs. CMS names the drug for 93 of them, across 6 drugs with 11 or more claims each, at $3,163 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Mann for performance year 2024, reported as part of a group. Dr. Mann accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mann as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Mann, published from 2018 to 2024. Dr. Mann has published most often in Can Urol Assoc J. Dr. Mann's most frequent co-authors are Jessica M. Delong, MD, Gustavo Abel Espino, MD and Joshua David Roth, MD.

CMS Open Payments shows 20 general payments to Dr. Mann from 2 drug and device companies from 2023 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Boston Scientific Corporation paid the most, $5,479.

Dr. Mann graduated from University Of Michigan Medical School in 2018.

Dr. Mann is in network with 11 carriers, including Aetna, Elevance and Medica. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.